Journal article icon

Journal article

Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case–cohort study

Abstract:
AIMS/HYPOTHESIS: Islet autoimmunity may progress to adult-onset diabetes. We investigated whether circulating odd-chain fatty acids (OCFA) 15:0 and 17:0, which are inversely associated with type 2 diabetes, interact with autoantibodies against GAD65 (GAD65Ab) on the incidence of adult-onset diabetes. METHODS: We used the European EPIC-InterAct case-cohort study including 11,124 incident adult-onset diabetes cases and a subcohort of 14,866 randomly selected individuals. Adjusted Prentice-weighted Cox regression estimated HRs and 95% CIs of diabetes in relation to 1 SD lower plasma phospholipid 15:0 and/or 17:0 concentrations or their main contributor, dairy intake, among GAD65Ab-negative and -positive individuals. Interactions between tertiles of OCFA and GAD65Ab status were estimated by proportion attributable to interaction (AP). RESULTS: Low concentrations of OCFA, particularly 17:0, were associated with a higher incidence of adult-onset diabetes in both GAD65Ab-negative (HR 1.55 [95% CI 1.48, 1.64]) and GAD65Ab-positive (HR 1.69 [95% CI 1.34, 2.13]) individuals. The combination of low 17:0 and high GAD65Ab positivity vs high 17:0 and GAD65Ab negativity conferred an HR of 7.51 (95% CI 4.83, 11.69), with evidence of additive interaction (AP 0.25 [95% CI 0.05, 0.45]). Low dairy intake was not associated with diabetes incidence in either GAD65Ab-negative (HR 0.98 [95% CI 0.94, 1.02]) or GAD65Ab-positive individuals (HR 0.97 [95% CI 0.79, 1.18]). CONCLUSIONS/INTERPRETATION: Low plasma phospholipid 17:0 concentrations may promote the progression from GAD65Ab positivity to adult-onset diabetes.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1007/s00125-023-05948-x

Authors

More by this author
Role:
Author
ORCID:
0000-0002-9497-2331
More by this author
Role:
Author
ORCID:
0009-0001-8408-0743


More from this funder
Funder identifier:
10.13039/100000009
Grant:
DK-26190
More from this funder
Funder identifier:
10.13039/501100009708
Grant:
NNF19OC0057274
More from this funder
Funder identifier:
10.13039/501100004587
Grant:
CPII20/00009
More from this funder
Funder identifier:
10.13039/501100004359
Grant:
2018-03035
More from this funder
Funder identifier:
10.13039/501100008546
Grant:
DIA2022-735


Publisher:
Springer
Journal:
Diabetologia More from this journal
Volume:
66
Issue:
8
Pages:
1460-1471
Publication date:
2023-06-10
DOI:
EISSN:
1432-0428
ISSN:
0012-186X


Language:
English
Keywords:
Pubs id:
1470806
Local pid:
pubs:1470806
Source identifiers:
W4380203301
Deposit date:
2026-05-08
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP